Bausch Health Companies Inc. Stock
Bausch Health Companies Inc. shows a slight decrease today, losing -€0.009 (-0.180%) compared to yesterday.
Our community identified positive and negative aspects for Bausch Health Companies Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bausch Health Companies Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -0.180% | -5.560% | -10.050% | -30.329% | -23.567% | -38.317% | -83.104% |
| Repligen Corp. | 0.410% | -0.897% | -12.723% | -17.492% | -25.488% | -32.810% | -33.534% |
| Opko Health Inc. | 3.350% | 0.323% | -2.489% | -39.042% | -8.714% | -10.018% | -73.055% |
| Amicus Therapeutics Inc. | 0.820% | -0.813% | 2.521% | 51.553% | 1.667% | 13.700% | 41.860% |
Comments
Bausch Health Cos (NYSE:BHC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat